Recent studies have shown that CXCL8 expression is significantly upregulated in several cancers, including prostate cancer, colorectal cancer, head and neck squamous cell carcinoma, osteosarcoma, and glioma. This evidence concerns the gene CXCL8 and central nervous system cancer.